Biopolymer matrices for controlled nutrient and molecule delivery
Our biopolymer matrices provide a sustainable, controlled-release system for agricultural nutrient application. By using a low-energy, solvent-free process, these materials enhance nutrient efficiency, reduce leaching, and offer scalability and cost-effectiveness.
Overview
Our innovative biopolymer matrices offer a sustainable solution for the controlled delivery of agricultural nutrients and active molecules. These matrices are designed to enhance nutrient efficiency by reducing leaching, thus providing a cost-effective and scalable option for agriculture. The use of biodegradable biopolymers allows for the slow release of key nutrients such as urea and micronutrients, making them an ideal alternative to traditional nutrient application methods. This approach not only supports environmental sustainability but also ensures compatibility with common fertilizers.
Technical specifications
- Biodegradable Biopolymers: Utilizes environmentally friendly materials for nutrient delivery.
- Controlled Release System: Offers tunable release profiles by incorporating different nutrients at macro and micro levels.
- Low-Energy Production: Developed through a solvent-free one-pot process that minimizes energy consumption and production costs.
- Bench-Scale Validation: Proven performance in aqueous systems, ensuring feasibility and near-term applicability.
- Scalability: Designed for scalable production with potential for pilot-scale expansion.
Technology readiness level
The biopolymer matrix technology is currently at a Technology Readiness Level (TRL) of 3. This indicates that the technology has been validated at the bench scale, with plans for further optimization and pilot-scale production feasibility studies over the next 6-12 months.
About Universidad de Buenos Aires
Universidad de Buenos Aires (UBA) is a comprehensive public research university and one of Latin America’s largest, with a broad academic footprint and high research intensity. Industry partners engage through campus-embedded laboratories, testing and analysis services, and a dedicated technology transfer entity that brokers contracts, IP licensing, and spinouts. Clinical integration with UBA‑affiliated hospitals and clinics enables access to diverse patient populations and pathways for translational studies, while its citywide footprint places teams near major corporate operations. Research is supported by competitive funding from national science and innovation agencies and international programs. A central corporate engagement function streamlines NDAs, MTAs, and sponsored research agreements to shorten time‑to‑collaboration.
delivered to your inbox.